Zentiva Competitors and Similar CompaniesClear all
Zentiva's competitors and similar companies include Swedish Orphan Biovitrum.
 Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | ||
Founding Date | Founding Date 2003 | Founding Date 2010 |
Type | Type Private | Type Public |
Tags | ||
Locations | ||
Employees | Employees 3,4721% increase | Employees 1,895 |
Financial | ||
Revenue (est.) | Revenue (est.) Kč2.3b (FY, 2021) | Revenue (est.) kr28.2b (FY, 2025) |
Cost of goods | Cost of goods Kč807.2m (FY, 2021) | Cost of goods kr6.2b (FY, 2025) |
Gross profit | Gross profit Kč1.5b (FY, 2021) | Gross profit kr22b (FY, 2025) |
Net income | Net income (Kč831.2m) (FY, 2021) | Net income kr476m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Swedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,895
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View company